Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD-MTX Induction and Consolidation for PCNSL
NCT01083342Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Jan 2010
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, cytarabine in primary central nervous system lymphoma (PCNSL), sponsored by Samsung Medical Center. Started Jan 2010; status: completed.
02
Drugs
methotrexatecytarabine
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT01083342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01083342.